Inovio Pharmaceuticals Inc [INO] stock is trading at $11.62, up 5.83%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The INO shares have gain 8.24% over the last week, with a monthly amount glided 51.70%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Inovio Pharmaceuticals Inc [NASDAQ: INO] stock has seen the most recent analyst activity on January 25, 2024, when Oppenheimer upgraded its rating to a Outperform but kept the price target unchanged to $4 for it. Previously, Maxim Group downgraded its rating to Hold on November 09, 2022. On November 01, 2022, downgrade downgraded it’s rating to Underperform but maintained its price target of $2 on the stock. Oppenheimer downgraded its rating to a Perform. BofA Securities upgraded its rating to Neutral for this stock on January 21, 2022, and upped its price target to $10.
Inovio Pharmaceuticals Inc [INO] stock has fluctuated between $3.89 and $12.79 over the past year. Inovio Pharmaceuticals Inc [NASDAQ: INO] shares were valued at $11.62 at the most recent close of the market.
Analyzing the INO fundamentals
Inovio Pharmaceuticals Inc [NASDAQ:INO] reported sales of 0.83M for the trailing twelve months, which represents a drop of -17.66%. Gross Profit Margin for this corporation currently stands at -38.1% with Operating Profit Margin at -173.0%, Pretax Profit Margin comes in at -162.4%, and Net Profit Margin reading is 3430.55%. To continue investigating profitability, this company’s Return on Assets is posted at 16.5, Equity is 18.29 and Total Capital is -1.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.88 points at the first support level, and at 10.15 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.26, and for the 2nd resistance point, it is at 12.91.
Ratios To Look Out For
For context, Inovio Pharmaceuticals Inc’s Current Ratio is 3.60. Further, the Quick Ratio stands at 3.60, while the Cash Ratio is 0.34. Considering the valuation of this stock, the price to sales ratio is 327.18, the price to book ratio is 2.26.
Transactions by insiders
Recent insider trading involved Zoth Lota S., Director, that happened on Jun 05 ’23 when 5700.0 shares were sold.
